Name

8 in 1

Alternate names

None

Primary Site

None

Histology

None

Radiation

None

Remarks

None

Drugs for 8 in 1

Name

Alternate Names

A-Methapred
Cordex Forte
Depmedalone
Depo-Medrol
Depo-Predate
Depoject
Depopred
Dopmedrol
Enpak Refill
Mar-Pred
Medrate
Medrol
Medrone
Methyl Prednisolone
Methylone
Pre-Dep
Promacortine
Rep-Pred
Urbason

Abbreviations

None

Category

Hormones and hormonal mechanisms

Subcategory

Glucocorticoid

NSC Number

019987
19987

Primary Site

None

Histology

None

Remarks

Code this drug as hormone therapy when given in multi-drug regimens.

Coding

This drug should be coded

Name

Alternate Names

Deticene
Detimedac
Dimethyl-triazeno-imidazole-carboxamide
DTIC-Dome
Fauldetic
Imidazole carboxamide
WR-139007

Abbreviations

DIC
DTIC
ICDT
ICT

Category

Chemotherapy

Subcategory

Antimetabolite
Nonclassic alkylating agent

NSC Number

45388
045388

Primary Site

Hodgkin's disease
melanoma
Neuroblastoma
Soft tissue sarcomas

Histology

None

Remarks

FDA approved on Hodgkin's lymphoma, and metastatic melanoma.

Coding

This drug should be coded

Name

Alternate Names

Belustine (nitrosourea)
CeeNu
Chloroethylcyclohexylnitrosourea
ICIG 1109
RB1509
WR-139017

Abbreviations

CCNU

Category

Chemotherapy

Subcategory

Alkylating agent

NSC Number

079037
79037

Primary Site

Brain tumors: primary or metastatic
Hodgkin lymphoma
Non-Hodgkin lymphoma

Histology

None

Remarks

Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Alternate Names

Cis-Platin
Cis-Platinum II#
Cisplatino (Spanish)
Cisplatinum
Cisplatyl
Neoplatin
Peyrone's chloride
Platinex
Platinol
Platinol-AQ
Platinol-AQ VHA Plus
Platinum

Abbreviations

CACP
CDDP
Cis-DDP
CPD
CPDC
CPDD
CPPD
DDP

Category

Chemotherapy

Subcategory

Alkylating agent
Platinum analog

NSC Number

119875

Primary Site

Bladder
ovarian
testicular cancer

Histology

None

Remarks

An alkylating antineoplastic agent. FDA approved uses on bladder, ovarian and testicular cancer; miscellaneous agent.

Coding

This drug should be coded

Name

Alternate Names

Ibenzmethyzin Hydrochloride
Matulane
Methylhydrazine
N-Methylhydrazine
Natulan
Natulane
Procarbazine hydrochloride
Ro-4-6467
Ro4-6467/1

Abbreviations

IBZ
MIH
PCB
PCH
PCI
PCZ

Category

Chemotherapy

Subcategory

Nonclassic alkylating agent

NSC Number

077213
77213

Primary Site

Brain tumors adjuvant and/or advanced disease
Cutaneous T-cell lymphoma
Hodgkin lymphoma
Non-Hodgkin lymphoma

Histology

None

Remarks

An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.

Coding

This drug should be coded

Name

Alternate Names

AC-1075
Alexan
Ara-cytidine
Arabinocytidine
Arabinosylcytosine
Beta-Arabinosylcytosine
Cytarabin
Cytarabine
Cytarabinoside
Cytosar
Cytosar-U
Cytosine Arabinoside
Cytosine arabinoside hydrochloride
Spongocytidine HCL
Tarabine
Tarabine PFS
U-19920
U-19920A
WR-28453

Abbreviations

ara-C
CA
HDA
HDARA-C

Category

Chemotherapy

Subcategory

Antimetabolite

NSC Number

063878
63878

Primary Site

ALL
AML
CML
head and neck
Hodgkin's disease
leukemia
Meningeal leukemia
NHL

Histology

None

Remarks

Antineoplastic agent; antimetabolite. FDA approved uses on Hodgkin's disease, leukemia; under investigation for Rx of Progressive Multifocal Leukoencephalopathy (PML)

Coding

This drug should be coded

Name

Alternate Names

Carbamo-hydroximic acid
Carbamohydroxamic acid
Carbamoyl oxime
Droxia
Hidrix
Hydrea
Hydreia
hydroxy-
Hydroxycarbamide
Hydroxycarbamine
Hydroxyl-urea
Hydura
Litaler
Litalir
Onco-Carbide
Oxyurea
SQ-1089
Urea
WR-83799

Abbreviations

HU
HUR
HYD

Category

Chemotherapy

Subcategory

Miscellaneous agent

NSC Number

032065
32065

Primary Site

Brain cancer
CML
Head and neck cancers
Melanoma
Ovarian cancer
Essential thrombocytosis

Histology

None

Remarks

FDA approved uses on chronic myelogenous leukemia, head and neck cancers, melanoma, and advanced ovarian cancer.

Coding

This drug should be coded

Name

Alternate Names

Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin

Abbreviations

LCR
VCR
VNCR

Category

Chemotherapy

Subcategory

Plant alkyloid--antimetabolite

NSC Number

067574
67574

Primary Site

None

Histology

None

Remarks

Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.

Coding

This drug should be coded
Glossary